← American Pharmacists Association (APhA)
FDANonrulemakingFDA-2026-D-7957

Container Closure Systems for Human Drugs and Biological Products; Draft Guidance for Industry; Availability

RIN
—
Last modified
Oct 14, 2026
Comment window
closed 23d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Oct 14, 2026 and Oct 14, 2026. 20 other organizations filed here. The comment window closed 23d ago.

What American Pharmacists Association (APhA) filed (1)

Oct 14, 2026· Comment from American Pharmacists Association· FDA-2026-D-7957-0066

Dear Deputy Commissioner Graham, The American Pharmacists Association (APhA) appreciates the opportunity to provide FDA and the Department of Health and Human Services (HHS) with comments on the "Container Closure Systems for Human Drugs and Biological Products; Draft Guidance for Industry." APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. Full comments are attached.

Download attachment ↓View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (20)

See everyone who commented →